Deutsche Bank
IMGN

Deutsche Bank’s Immunogen Inc IMGN Stock Holding History

Deutsche Bank’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500
Closed -$3K – 6116
2014
Q4 		$3K Buy
+500
New +$4.57K ﹤0.01% 5972
2013
Q3 		– Sell
-1,200
Closed -$1K – 5783
2013
Q2 		$1K Buy
+1,200
New +$19.4K ﹤0.01% 5307

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deutsche Bank's IMGN Position: Q1 2024 in Review

Deutsche Bank sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,065,880 shares — an estimated $31.6M sold.

Deutsche Bank first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $62.4M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Deutsche Bank reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 1,065,880 Immunogen Inc shares in Q1 2024, an estimated $31.6M.
  • Deutsche Bank first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Deutsche Bank's Immunogen Inc position peaked at $62.4M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.